Compare ACCO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCO | SOPH |
|---|---|---|
| Founded | 1893 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 373.2M | 367.7M |
| IPO Year | 2005 | 2021 |
| Metric | ACCO | SOPH |
|---|---|---|
| Price | $3.51 | $4.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 608.9K | 112.4K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | ★ 8.26% | N/A |
| EPS Growth | ★ 141.51 | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $1,524,700,000.00 | N/A |
| Revenue This Year | $5.79 | $16.16 |
| Revenue Next Year | $4.84 | $17.56 |
| P/E Ratio | $8.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.20 | $2.58 |
| 52 Week High | $4.82 | $5.70 |
| Indicator | ACCO | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 26.37 | 47.33 |
| Support Level | $3.34 | $4.54 |
| Resistance Level | $3.86 | $4.86 |
| Average True Range (ATR) | 0.13 | 0.29 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 4.09 | 59.79 |
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.